SAT-172 Continuous, Prolonged Treatment with the Oligonucleotide IMT504 in Diabetic NOD Mice Greatly Improves All Parameters of the Diabetic Condition

por Bianchi, Stefania, Lavignolle Heguy, María, Montaner, Alejandro, Libertun, Carlos, Lux-Lantos, Victoria, Bianchi, Maria
Publicado 2019

SAT-165 Does Oligodeoxynucleotide IMT504 Have Any Effect On Beta Cells? A Preliminary Study On MIN6B1 Cell Line

por Converti, Ayelén, Bianchi, Maria Silvia, Montaner, Alejandro, Libertun, Carlos, Lux Lantos, Victoria, Bonaventura, María Marta
Publicado 2019

IMT504 protects beta cells against apoptosis and maintains beta cell identity, without modifying proliferation

por Converti, Ayelén, Bianchi, María Silvia, Martinez, Mario D., Montaner, Alejandro D., Lux‐Lantos, Victoria, Bonaventura, María Marta
Publicado 2023

SAT035 Oligonucleotide IMT504 Markedly Improves Metabolic Sindrome And Type 2 Diabetes In High-Fat Diet Fed Mice

por Domé, Laila, Riaño Gomez, Juan Manuel, Marta Bonaventura, María, Olga Fernandez, Marina, Daniel Montaner, Alejandro, Adela Lux-Lantos, Victoria, Silvia Bianchi, Maria
Publicado 2023

PyNTTTTGT and CpG Immunostimulatory Oligonucleotides: Effect on Granulocyte/Monocyte Colony-Stimulating Factor (GM-CSF) Secretion by Human CD56(+) (NK and NKT) Cells

por Rodriguez, Juan M., Marchicio, José, López, Mariela, Ziblat, Andrea, Elias, Fernanda, Fló, Juan, López, Ricardo A., Horn, David, Zorzopulos, Jorge, Montaner, Alejandro D.
Publicado 2015

Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy

por Zorzopulos, Jorge, Opal, Steven M, Hernando-Insúa, Andrés, Rodriguez, Juan M, Elías, Fernanda, Fló, Juan, López, Ricardo A, Chasseing, Norma A, Lux-Lantos, Victoria A, Coronel, Maria F, Franco, Raul, Montaner, Alejandro D, Horn, David L
Publicado 2017